Chemical Compound
BROMOCRIPTINE MESYLATE
CAS Registry Number
22260-51-1
Primary Record
BROMOCRIPTINE MESYLATE
- In stock
- 8,319 g
- Purity
- 98.3 %
- CAS
- 22260-51-1
Compound Identifiers & Properties
- CAS
- 22260-51-1
- PubChem CID
- 31100
- SMILES
- CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O.CS(=O)(=O)O
- Canonical SMILES
- CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CS(=O)(=O)O
Names & Synonyms
- BROMOCRIPTINE MESYLATE
- Parlodel
- Pravidel
- Cycloset
- Bromocriptine mesilate
- Bagren
- Bromocryptine mesylate
- Bromergon
- 22260-51-1
- CB-154 mesylate
- Bromocriptine methanesulfonate
- Cb-154 mesilate
- 2-Bromoergocryptine
- Bagre n
- 2-bromoergocriptine
- Parlodel (TN)
- Prestwick_771
- 2-Bromoergocryptine Mesylate
- Bromocriptine (mesylate)
- FFP983J3OD
- Mesylate, Bromocriptine
- Bromocryptine methanesulfonate
- RefChem:56424
- UNII-FFP983J3OD
- (+)-Bromocriptine methanesulfonate
- AC1L1KXP
- Bromocriptine mesylate [USAN]
- 2-Bromo-alpha-ergocryptine mesylate
- C33H44BrN5O8S
- Bromocriptine mesilate CRS
- DTXSID6020197
- BROMOCRIPTINEMESYLATE
- DTXCID00197
- CHEBI:3182
- 2 Bromoergocryptine Mesylate
- CB 154
- SCHEMBL40559
- 2-Bromo a-Ergocryptine Mesylate
- Bromocriptine mesylate (USP)
- C32H40BrN5O5.CH4O3S
- Mesylate, 2-Bromoergocryptine
- EINECS 244-881-1
- CB-154
- NOJMTMIRQRDZMT-GSPXQYRGSA-N
- Bromocriptine mesilate (JP18)
- Bromocriptine mesylate [USAN:USP]
- 2-Bromo-alpha-ergokryptine-mesilate
- CHEMBL1200503
- NSC-755915
- SCHEMBL29360283
- 2-Bromo ?-Ergocryptine Mesylate
- 2-Bromo alpha-Ergocryptine Mesylate
- ERK5-1O03
- CB 154 methanesulfonate (salt)
- 2-Bromo |A-Ergocryptine Mesylate
- MFCD00069218
- HMS1568I04
- HMS3260D03
- HMS3411K09
- HMS3675K09
- HMS3712I04
- 2 Bromoergocryptine Methanesulfonate
- 2-Bromoergocryptine Methanesulfonate
- CID31100
- MSK11358
- 2-Bromo-alpha-ergocryptine methanesulfonate
- 2-Bromoergocryptine monomethanesulfonate (salt)
- BROMOCRIPTINE MESILATE [JAN]
- Tox21_303597
- Tox21_500171
- HB1813
- HY-12705A
- Methanesulfonate, 2-Bromoergocryptine
- MFCD09028065
- NSC169774
- 2-Bromine-alpha-ergocryptine methanesulfonate
- 2-Bromo-alpha-ergokryptine-mesilate [German]
- BROMOCRIPTINE MESYLATE [VANDF]
- .alpha.-Ergocryptine, methanesulfonate
- AKOS015896276
- BROMOCRIPTINE MESILATE [MART.]
- BROMOCRIPTINE MESILATE [WHO-DD]
- BROMOCRIPTINE MESYLATE [USP-RS]
- CCG-220121
- CCG-221475
- CS-6048
- CS-I-00026
- EBC-102075
- FB19032
- LP00171
- LS-7234
- NSC 755915
- NSC-169774
- NCGC00257268-01
- NCGC00260856-01
- AN-17214
- BB164266
- alpha-Ergocryptine, 2-bromo-, methanesulfonate
- Bromocriptine mesylate - Bio-X trade mark
- BROMOCRIPTINE METHANESULFONATE [MI]
- BROMOCRIPTINE MESYLATE [ORANGE BOOK]
- C32-H4O-Br-N5-O5.C-H4-O3-S
- CAS-22260-51-1
- 2-Bromo-a-ergocryptine methanesulfonate salt
- B6298
- BROMOCRIPTINE MESILATE [EP MONOGRAPH]
- EU-0100171
- FT-0663681
- NS00084669
- BROMOCRIPTINE MESYLATE [USP MONOGRAPH]
- B 2134
- D00780
- D81822
- 2-Bromo-.alpha.-ergocryptine monomethanesulfonate
- 93201-EP2272825A2
- 93201-EP2305633A1
- Bromocriptine mesilate for system suitability CRS
- A903911
- SR-01000075356
- SR-01000597796
- 22260-51-1, 25614-03-3 [bromocriptine]
- Ergocryptine, 2-bromo-, monomethanesulfonate (salt)
- I06-2158
- SR-01000075356-1
- SR-01000597796-1
- SR-01000597796-2
- Q27105974
- 2-BROMOERGOCRYPTINE MONOMETHANESULPHONATE (SALT)
- B2693-463773
- 2-Bromo-12'-hydroxy-5'alpha-isobutyl-2'-isopropylergotaman-3',6',18-trione monomethanesulphonate
- Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, monomethanesulfonate (salt), (5'alpha)-
- 2-Bromo-alpha-ergocryptine methanesulfonate salt, 98% - 100mg 100mg
- (+)-2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6'-18-trione methanesulfonate salt
- (5 inverted exclamation mark |A)-2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione Methanesulfonate
- (5'?)-2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione methanesulfonate
- (5'a)-2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione mesylate
- (5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-2'-(propan-2-yl)-3',6',18-trioxoergotaman methanesulfonate
- (5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-3',6',18-trioxo-2'-(propan-2-yl)ergotaman methanesulfonate (salt)
- (5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman methanesulfonate
- (5'S)-2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione monomethanesulfonate
- (5xi,5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman methanesulfonate (salt)
- (5xi,5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman methanesulfonate (salt)
- (6aR,9R)-5-Bromo-N-((2R,5S,10aS,10bS)-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxooctahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide methanesulfonate
- (6aR,9R)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;methanesulfonic acid
- (6aR,9R)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-isobutyl-4-isopropyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;methanesulfonic acid
- 244-881-1
- Bromocriptine mesilate; (6aR,9R)-5-Bromo-N-[(2R,5S,10aS,10bS)-10b-hydroxy-2-(1-methylethyl)-5-(2-methylpropyl)-3,6-dioxooctahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl]-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide monomethanesulfonate; Ergocryptine, 2-bromo-, monomethanesulfonate (salt) (8CI); 8H-Oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine, ergotaman-3',6',18-trione deriv.; Indolo[4,3-fg]quinoline, ergotaman-3',6',18-trione deriv.; (+)-Bromocriptine methanesulfonate; Bagren; Bromocriptine mesylate; Bromocriptine methanesulfonate; Bromocryptine mesylate; Bromocryptine methanesulfonate; CB 154; Cycloset; Parlodel; Pravidel; Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5alpha)-, methanesulfonate (1:1); Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'alpha)-, monomethanesulfonate (sa
- Ergotaman-3', 6',18-triona, 2-bromo-12'-hidroxi-2'-(1-metiletil)-5-(2-metilpropil)-, (5alfa)-, Metanosulfonato ( 01:01)
- Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'.alpha.)-, monomethanesulfonate (salt)
- Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5.alpha.)-, methanesulfonate (1:1)
- ERGOTAMAN-3',6',18-TRIONE, 2-BROMO-12'-HYDROXY-2'-(1-METHYLETHYL)-5'-(2-METHYLPROPYL)-, MONOMETHANESULFONATE (SALT), (5'.ALPHA.)-
- ERGOTAMAN-3',6',18-TRIONE, 2-BROMO-12'-HYDROXY-2'-(1-METHYLETHYL)-5'-(2-METHYLPROPYL)-, MONOMETHANESULPHONATE (SALT), (5'.ALPHA.)-
- Methanesulfonic acid--2-bromo-12'-hydroxy-5'alpha-(2-methylpropyl)-3',6',18-trioxo-2'-(propan-2-yl)ergotaman (1/1)